microarray drug

Aliases

microarray technology, microarrays

External links

DrugBank · PubChem

No related entities found.

Mentioned in (14)

Papers in which this entity is mentioned.

• Evaluating the transcriptional fidelity of cancer models. (2021)
• Determining cell type abundance and expression from bulk tissues with digital cytometry. (2019)
• RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types. (2019)
• Profiling Tumor Infiltrating Immune Cells with CIBERSORT. (2018)
• The evolution of tumour phylogenetics: principles and practice. (2017)
• The impact of structural variation on human gene expression. (2017)
• Comparison of RNA-seq and microarray-based models for clinical endpoint prediction. (2015)
• A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium. (2014)
• MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. (2014)
• Differential expression in RNA-seq: a matter of depth. (2011)
• DNA copy number, including telomeres and mitochondria, assayed using next-generation sequencing. (2010)
• Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidy. (2009)
• RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. (2008)
• PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. (2007)

Merged raw entities (3)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.